Thanks J8/Hoyland. I'm a slow learner sometimes. I went back and listened to the presentation from the 2013 roadshow presentation and that confirms what you said. Interestingly, in that presentation, Peter French says that the first cohort get a sub-therapeutic dose, but that the second cohort get a low therapeutic dose, so hopefully we see some decrease in viral load with the second cohort of 3 patients.
BLT Price at posting:
$1.03 Sentiment: Buy Disclosure: Held